Levosimendan and Cardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 1, 2010, Pages 210-

  De Santis, Vincenzo ^a   Vitale, Domenico ^a   Tritapepe, Luigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOSIMENDAN; TROPONIN I;

CARDIOPULMONARY BYPASS; HEART STROKE VOLUME; HEART SURGERY; HUMAN; LETTER; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; HUMANS; HYDRAZONES; PYRIDAZINES; TROPONIN I;

EID: 74449089563     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.01.008     Document Type: Letter

References (5)

1. De Hert S.G., Lorsomradee S., vanden Eede H., et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth 22 (2008) 699-705
2. Tritapepe L., De Santis V., Vitale D., et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-A pilot study. Br J Anaesth 96 (2006) 694-700
3. Tritapepe L., De Santis V., Vitale D., et al. Levosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 102 (2009) 198-204
4. Yao Z., and Gross G.J. Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs. Am J Physiol 267 (1994) 1888-1894
5. Mizumura T., Auchampach J.A., Linden J., et al. PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res 79 (1996) 415-423